FindTrial
Sign In

Effect of the Homoeopathic Medicine Solidago virgaurea in the treatment of albumin in urine of Diabetic patients

An Open Labelled Prospective Clinical Case Series Study to assess the levels of Microalbuminuria of Diabetic Nephropathy Patients treated with Solidago virgaurea 6CH - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/049934
Enrollment
30
Registered
2023-02-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E112- Type 2 diabetes mellitus with kidney complications

Interventions

Intervention1: Solidago virgaurea 6CH: 5 Medicated globules of 30 size will be prescribed orally morning and night for a minimum 60 days before food Control Intervention1: NIL: NIL

Sponsors

Vinayaka Missions Homoeopathic Medical College and Hospital
Lead Sponsor
Central Council for Reseach in Homoeopathy
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Diabetic Nephropathy patients with ACR value >2.5mg/mmol creatinine in males ACR value >3.5mg/mmol creatinine in females

Exclusion criteria

Exclusion criteria: 1. Patients suffering from other renal diseases 2. Gestational diabetic patients 3. Diabetes Mellitus patients with Multi-System Involvement

Design outcomes

Primary

MeasureTime frame
Reduction of ACR value Reduction of urine albumin excretion levels, control of blood glucose levels, Improvement of e-GFRTimepoint: 60 days—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr H Venkatesan

Vinayaka Missiosn Homoeopathic Medical College and Hospital ,Salem

venkathompath@gmail.com9865134561

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026